Case report: functioning pituitary macroadenoma in Boston Terrier
DOI:
https://doi.org/10.47847/fagropec.v14n1a8Keywords:
Cushing's, adenoma, magnetic resonance imagingAbstract
An eight-year-old male Boston Terrier breeding canine was brought to Clinica San Miguel Medicina Veterinaria, with a six-month history of temperament changes, marked lethargy and alteration of liver function with previous treatment in another veterinary center. The patient manifested increased hepatic transaminases ALT and GGT, ultrasound alteration in adrenal glands with increased size, a diagnosis of hyperadrenocortisism was made by means of suppression test with dexamethasone at low doses with increased cortisol; its cause was confirmed by brain contrasted MRI in which pituitary mass was evidenced; leading to the diagnosis of pituitary adenoma producing ACTH, consistent with what is reported in literature and therapeutic alternatives with its clinical signs.
Downloads
References
Chang H., Perales C., R., & Tabacchi N., L (2017). Frecuencia de Neoplasias en Caninos de 0 a 5 Años Diagnosticadas en el Laboratorio de Histopatología Veterinaria de la Universidad Nacional Mayor de San Marcos (2003-2014). Revista de Investigaciones Veterinairas Lima, Perú: Rev Inv Vet Peru, Vol 28, N°4, 2017. https://doi.org/10.15381/rivep.v28i4.13867
Membiela – Sánchez F., Coscollá – Palmer A., Borrego – Massó J.F. (2019) Urgencias oncológicas. Clin. Vet. Peq. Anim. Vol 39, N°1.
Horta R.S., Martins B.D., Lavalle G.E., Costa M.D., De Araújo R.B. (2013) Neoplasias intracranianas em pequenos animais-Revisão de literatura. Acta Vet. Brasilica; 7(4):272-281
Freeman, P. M., & Ives, E. (2020). A practical approach to neurology for the small animal practitioner A practical approach to neurology for the small animal practitioner. Wiley-Blackwell.
Menchetti, M., De Risio, L., Galli, G., Bruto Cherubini, G., Corlazzoli, D., Baroni, M., & Gandini, G. (2019). Neurological abnormalities in 97 dogs with detectable pituitary masses. The Veterinary Quarterly, 39(1), 57–64. https://doi.org/10.1080/01652176.2019.1622819
Behrend ES., (2015). Hiperadrenocorticismo canino. En: EC Feldman, RW Nelson, CE Reusch, et al., eds. Endocrinología canina y felina . 4ª ed. San Luis: Elsevier Saunders: 377 – 451 .
Bennaim, M., Shiel, R. E., & Mooney, C. T. (2019). Diagnosis of spontaneous hyperadrenocorticism in dogs. Part 1: Pathophysiology, aetiology, clinical and clinicopathological features. Veterinary Journal (London, England: 1997), 252(105342), 105342. https://doi.org/10.1016/j.tvjl.2019.105342
Nelson, R. W., Ihle, S. L., & Feldman, E. C. (1989). Pituitary macroadenomas and macroadenocarcinomas in dogs treated with mitotane for pituitary-dependent hyperadrenocorticism: 13 cases (1981-1986). Journal of the American Veterinary Medical Association, 194(11), 1612–1617. https://europepmc.org/article/med/2753785
Dewey, C. W., & da Costa, R. C. (2015). Practical guide to canine and feline neurology (Curtis W. Dewey & R. C. da Costa, Eds.; 3a ed.). Standards Information Network. https://books.google.at/books?id=JSWJCgAAQBAJ
Garosi, L., & Lowrie, M. (2013). The neurological examination. En BSAVA Manual of Canine and Feline Neurology (pp. 1–24). British Small Animal Veterinary Association.
Platt, S. y Olby, N. (2013). Urgencias neurológicas. BSAVA manual de neurología canina y felina , 388-408.
Ettinger, S. J., & Feldman, E. C. (2006). Tratado de medicina interna Veterinaria, 2 vols. (E-dition + CD-Rom): Enfermedades del perro Y El Gato (6a ed.). Elsevier.
Vicente, A. (2016) Radiocirugia hipofisiaria con gamma knife en perros con tumor hiperadrenocorticismo hipofisiario. Tesis Doctoral. Madrid, España: Universidad Complutense de Madrid, 2016.
Chaves, R. O., Feranti, J. P. S., Copat, B., Ripplinger, A., França, R. T., Kommers, G. D., Fighera, R. A., & Mazzanti, A. (2018). Neoplasias encefálicas em 40 cães: aspectos clínico-epidemiológicos e patológicos. Pesquisa veterinaria brasileira [Brazilian journal of veterinary research], 38(4), 734–740. https://doi.org/10.1590/1678-5150-pvb-4962
Rojas Z, D., Palma F, A., & Wohllk G, N. (2008). Manejo de los adenomas hipofisiarios. Revista Chilena de Neuro-Psiquiatría, 46(2), 140–147. https://doi.org/10.4067/s0717-92272008000200009
Clemente M., Campos A., & Yeste D. (2018). Tratamiento prenatal de la HSC. Revista Esp Endocrinología Pediátrica Volumen 9 págs. 26- 29
Tritos, N. A., & Biller, B. M. K. (2019). Current management of Cushing’s disease. Journal of Internal Medicine, 286(5), 526–541. https://doi.org/10.1111/joim.12975
Leal-Cerro, A., Moreno, A. S., Mangas, M. A., Justel, A. L., & Webb, S. (2009). Tratamiento farmacológico y seguimiento del síndrome de Cushing. Endocrinología y Nutrición, 56(4), 187-194.
Boretti, F. S., Holzthuem, J., Reusch, C. E., & Sieber-Ruckstuhl, N. S. (2016). Lack of association between clinical signs and laboratory parameters in dogs with hyperadrenocorticism before and during trilostane treatment. Schweizer Archiv für Tierheilkunde, 158(9), 631-638.
Torres, S. C. (2019). Universidad de chile facultad de ciencias veterinarias y pecuarias escuela de ciencias veterinarias monografía terapias médicas actuales para el tratamiento de hiperadrenocorticismo de origen hipofisiario en perros. Uchile.cl. Recuperado el 25 de noviembre de 2021, de https://repositorio.uchile.cl/bitstream/handle/2250/170694/Terapias-m%c3%a9dicas-actuales-para-el-tratamiento-de-hiperadrenocorticismo-de-origen-hipofisiario-en-perros.pdf?sequence=1&isAllowed=y
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.